More than an intermediary business.
In recent years, the number of cross-border medical patients has gradually increased. Relevant data show that under the trend of rapid development and aging of high-net-worth individuals, the number of patients visiting medical institutions in overseas countries has exceeded 500,000 in 2017. However, it is also limited by the cost issue. It is also criticized by many people in the industry for going abroad for medical treatment because it involves the cost of treatment and services for the patients themselves, the cost of accompanying families, the cost of living in different places, and the loss of family members due to their inability to work. Income and so on.
In this regard, at the first International Medical Insurance Forum held last month, some experts pointed out that from a global perspective, the combination of high-end commercial medical insurance and high-end medical services must be two-wheel drive. QTC Care CEO Lu Hao pointed out in an interview that “the entire market for all Chinese overseas medical treatment in 2019 is about 3 billion yuan, but most of the 3 billion people so far are self-sufficient; I think if the average family pays only 3000 per year If you have money, you can go out. If you have 100 times or 1000 times, you can go overseas for treatment when you are sick in the future. The market size should increase exponentially.”
However, At present, commercial medical insurance has not been fully developed in the case of domestic public medical institutions, especially the development of high-end health insurance is not sufficient, which has inhibited the development of this market. The lack of payment and the mismatch between cross-border medical needs have become a major contradiction in the market. Although high-end medical insurance coverage has continued to rise in recent years, the market is optimistic, and major companies have tried water, but few have succeeded.
Image Source: Oriental IC
Where is the problem, how to solve it becomes a common concern. Industry pointed out for two reasons: first , local and foreigners The nature of high-end medical needs is completely different. It is difficult to meet the needs of local people for overseas medical treatment at the same time.Secondly, product design and risk control, service efficiency can not keep up.
Don’t talk about the technology and efficiency of the product itself. Is there a kind of insurance that can be tailor-made for local people? Based on overseas medical services, QTC Care has explored a new international medical insurance model, which jointly developed and listed a long-term overseas cancer medical insurance with an insurance company. Its lifetime insurance coverage is 6 million. The service includes the first diagnosis and each time. Follow-up cancer and precancerous lesions, provide overseas experts with second opinion treatment services, follow-up visits and follow-up and continuous medication services after returning to China.
QTC Care started from cross-border medical care. At the beginning of its establishment, the business focus was on the one-stop management platform for cancer, which relied on the US oncology medical resources to provide cancer prevention consultation, medical examination to the United States, and international remote video diagnosis and treatment for Chinese patients. And medical services such as going to the United States. It has received nearly $50 million in Series A financing from Tencent.
With further understanding of the market, QTC Care has been upgraded to a health technology company that can quantify disease prevention and control goals ( ever This has been reported in detail), and the first thing to do is to introduce insurance. Lu said, “Insurance itself is a very difficult object. Medical itself is also very difficult. QTC Care hopes to combine these two products. Insurance control fees, Data Driven Health.”
In fact, cross-border medical service providers are not new to exploring high-end health insurance, as in November 2017, Shenno has cooperated with U.S. Health Insurance (UHC), the largest health insurance company in the United States, to launch the “China Self-funded Patient Treatment Program”, trying to go abroad for treatment. Customers reduce the financial burden. However, QTC Care wants to do more than that.
Specifically, QTC Care has included two “electronic medicines” in its insurance services: “Mine Tea Program – Weight Loss Electronic Medicine” is intended to be a big data-based behavioral intervention program that moves through The Internet helps participants reduce weight to achieve the goal of reducing the risk of chronic diseases and serious illnesses; in addition, the Kapok Project– Anti-cancer electronic drugs are based on evidence-based medicine, through online behavioral intervention models, designed to help cancer patients improve their quality of life and reduce overall medical expenditures to alleviate family members other than those mentioned above. The burden.
Lu Yi told that both products have a underlying logic, which is to first turn the high risk of major diseases into low risk through the rice tea plan; even if some will get sick, QTC Care’s critical care services can be used, and the Kapok program can also work for relatives who are under heavy pressure. “These things are combined to provide a complete closed-loop solution for the family.”
However, the closed-loop solution also relies on the company’s deep involvement in the design and sale of insurance products. According to Lu Wei, QTC will work with insurance companies to design products in depth. Although insurance companies understand insurance, QTC will help them to package their customers’ insurance products into insurance products. The insurance company then issues a pricing release; then, QTC will help train all insurance salespeople; when the customer becomes ill, all QTC services will follow and integrate US hospital resources.
In addition, some insiders pointed out that high-end medical insurance is still facing another dilemma, that is, products, services and risk control can not keep up; in addition, most of them pay directly from the direct payment, the efficiency of claims, the hospital network, There is still a lack of expert networks and post-rehabilitation.
How to break through the corresponding difficulties? Lu Yan explained, “We feel that even if the patient goes to the United States, he will eventually return to China. Therefore, he hopes that he can have a good case for all the treatments in the United States to the Chinese doctors in order to carry out follow-up treatment. Partly, we went to the experts who were treated at the time in the United States. For this reason, we independently developed a case system that is both in line with US policy and China’s second-class insurance. All patient cases will be concentrated here.”